Big Pharma CEOs Rake in Millions in Compensation While Patients Struggle With Sky-High Drug Prices

Big Pharma Can Tweak Drugs to Keep Generics Off the Market

Taking advantage of a broken patent system, Big Pharma is making minor tweaks to medications just to keep affordable generics off the market, a new report suggests. They’ve made billions of dollars in the process.

Big Pharma CEOs Rake in Millions in Compensation While Patients Struggle With Sky-High Drug Prices

BioNTech’s Dr. Ugur Sahin topped Fierce Pharma‘s 2024 list with $287 million, while Pfizer’s Albert Bourla ($24.6 million) and Eli Lilly’s David Ricks ($29.2 million) ranked among the highest-paid, reflecting booming drug sales (e.g., weight-loss drugs, COVID-19 vaccines). Executives’ multimillion-dollar payouts contrast sharply with soaring prescription costs, eroding public trust as patients struggle to afford medications like insulin. Major f…

CEOs of BioNTech, Pfizer, J&J and Merck Make List of Highest-Paid Pharma Execs – altnews.org

by Brenda Baletti, Ph.D., Childrens Health Defense: The CEO of Germany’s BioNTech outearned all his fellow pharma CEOs in 2024,